COVID-19 Laboratory Challenges and Lessons: Part 1
The COVID-19 pandemic has impacted laboratories across the world. Some laboratories have been labeled non-essential and face the challenges of being forcibly idled. Other laboratories have been labeled essential and face the challenge of keeping workers safe and delivering for their stakeholders during this crisis.
COVID-19 Vaccine in 2020 Highly Unlikely, Experts Caution
peculation that a vaccine for COVID-19 might be widely available by the end of this year is overly optimistic, three Duke experts said Wednesday.
Duke University to open huge 273,000 square foot lab at Parmer RTP
Duke University’s School of Medicine research arm is building on its recent success in acquiring grants for immunology, infectious diseases and clinical trials with a move to Research Triangle Park.
DHVI receives $17 million from NC state legislature to develop preventive vaccines against SARS-CoV-2
The State of North Carolina enacted Session Law 2020-4, an Act to Provide Aid to North Carolinians in Response to the Coronavirus Disease 2019 Crisis, also known as the 2020 COVID-19 Recovery Act.
Newswise Live Expert Panel: Vaccine and Treatment Leaders for COVID-19
Panelists discussed a variety of topics including: drug trials and updates on the remdesivir and hydroxychloroquine studies, reports of possible vaccine progress, treating COVID in the ICU, public health policy, research on how the pandemic is progressing, safe re-openings, successful interventions and what still needs to be done.
Duke Experts: A Trusted Source for Policymakers
The need for trusted knowledge and expertise is most valuable during a time of crisis. In response to the coronavirus, experts across Duke University and Duke Health have been critical in informing policymakers at the local, state, and national level. Scholars, doctors, and Duke administrators collaborate with policymakers every day, but have been increasingly engaged on public policy decisions as our nation responds to the unprecedented COVID-19 pandemic.
Why do some people infected with coronavirus fare worse than others? School of Medicine researchers search for answers
When infected with SARS-CoV-2, why do some people—such as smokers and older adults— have extreme respiratory and cardiovascular distress while others have no symptoms at all?
Duke on the Forefront of COVID-19 Research
We are so proud of our DHVI and Duke RBL researchers and staff, who are working tirelessly to ensure the safety our healthcare workers and develop a vaccine and therapeutic countermeasures against COVID-19. In this video, Dr. Greg Sempowski, Director of the Duke Regional Biocontainment Laboratory (RBL), talks about the efforts of this extraordinary team and the in-house resources at Duke.
Duke Starts Novel Decontamination of N95 Masks to Help Relieve Shortages
Facing a critical shortage of N95 face masks that block the coronavirus, Duke Health research and clinical teams have confirmed a way to use existing vaporized hydrogen peroxide methods to decontaminate the masks so they can be reused.
Duke leverages cryo-electron microscope facility in the race for coronavirus vaccine
Although most research laboratories at Duke University are shuttered to prevent future transmission of the Covid-19 coronavirus, one of the few to remain open houses a powerful machine that Duke researchers think will be instrumental in developing a vaccine for the virus.